Finance

Lists
GHRS:NASDAQ
GH Research PLC
$20.50
-1.73%
(-0.36) 1D
$20.50
0.00% (0.00)
After hours
Closed: Nov 2, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GHRS...
Open
$20.91
High
$21.28
Low
$19.95
Mkt. cap
1.41B
Avg. vol.
332.89K
Volume
0.00
52-wk high
$31.44
52-wk low
$12.04
EPS
-$0.99
Beta
1.32
Shares outstanding
68.64M
No. of employees
73
Open
$20.91
High
$21.28
Low
$19.95
Mkt. cap
1.41B
Avg. vol.
332.89K
Volume
0.00
52-wk high
$31.44
52-wk low
$12.04
EPS
-$0.99
Beta
1.32
Shares outstanding
68.64M
No. of employees
73
News stories
From web sources and news partners
About GH Research PLC
CEOTheis Terwey
Employees73
Founded2018
Headquarters-
SectorPharmaceutical industry
Websiteghres.com
Analyst ratings
Based on 9 analysts giving stock ratings to GHRS in the past 3 months
Strong buy
Buy
9
Hold
0
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for GHRS in the last 3 months.
Highest
Current $20.50
$65.00 (+217.07%)
Average
$43.38 (+111.61%)
Lowest
$38.00 (+85.37%)
Analyst
Recommendation
Action
Price target
Projected
Date
Benjamin Burnett
Wells Fargo
Buy
Maintained
$44.00
+114.6%
08/31/2026
Patrick Trucchio
H.C. Wainwright
Buy
Reiterated
$65.00
+217.1%
08/10/2026
Sumant Kulkarni
Canaccord Genuity
Buy
Maintained
$39.00
+90.2%
08/06/2026
Joshua Schimmer
Cantor Fitzgerald
Buy
Reiterated
$40.00
+95.1%
08/06/2026
Eddie Hickman
Guggenheim
Buy
Reiterated
$40.00
+95.1%
08/06/2026
Ritu Baral
TD Cowen
Buy
Maintained
-
-
08/06/2026
Ami Fadia
Needham
Buy
Maintained
$39.00
+90.2%
08/06/2026
Paul Matteis
Stifel Nicolaus
Buy
Maintained
$38.00
+85.4%
08/06/2026
Brian Abrahams
RBC Capital
Buy
Maintained
$42.00
+104.9%
08/06/2026
Jason Butler
Citizens JMP
Buy
Maintained
$39.00
+90.2%
05/15/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
10.57M
11.39M
12.38M
12.40M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.00M
5.33M
6.37M
7.06M
Operating expense
16.54M
16.70M
18.75M
19.45M
Total operating expenses
16.54M
16.70M
18.75M
19.45M
Operating income
-16.54M
-16.70M
-18.75M
-19.45M
Other non operating income
-
-
-
-
EBT including unusual items
-14.02M
-14.14M
-18.97M
-15.15M
EBT excluding unusual items
-15.80M
-15.84M
-20.50M
-16.75M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-14.02M
-14.14M
-18.97M
-15.15M
Net profit margin
-
-
-
-
Earnings per share
-0.23
-0.22
-0.31
-0.23
Interest and investment income
1.00M
812.00K
666.00K
1.05M
Interest expense
-21.00K
-90.00K
-84.00K
-83.00K
Net interest expenses
980.00K
722.00K
582.00K
966.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-16.45M
-16.68M
-18.66M
-19.36M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps